GRI Bio GRI
NASDAQ GRI
$1.96 +0.03 (+1.55%)
At close: Oct 1, 2026 · 4:00 PM EDT

GRI Bio (GRI) EV to FCF (2023)

Updated

GRI Bio's (GRI) EV to FCF was 216.30 for Q1 2023.

Analysis

GRI Bio (GRI) EV to FCF (2023) Analysis & Trends

Over the twelve months ended Mar 31, 2023, GRI Bio's EV to FCF came in at 196.83.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 GRI Bio 3.48 Mn 3.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 216.30
API Access

GRI Bio EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=GRI&period=max&api_key=YOUR_API_KEY